Review, Reviews
Live longer on MARS: a yeast paradigm of mitochondrial adaptive ROS signaling in aging
Gerald S. Shadel
In this article, the potential relevance of Mitochondrial Adaptive ROS Signaling (MARS) to the human disease Ataxia-Telangiectasia and as a potential anti-aging target is discussed.
Prokaryotic Argonautes – variations on the RNA interference theme
John van der Oost1, Daan C. Swarts1, Matthijs M. Jore1,2
This article comments on work published by Swarts et al. (Nature, 2014), which demonstrates that Argonaute family protein of the bacterium Thermus thermophilus acts as a barrier for the uptake and propagation of foreign DNA.
Longevity pathways and maintenance of the proteome: the role of autophagy and mitophagy during yeast ageing
Belém Sampaio-Marques1,2, William C. Burhans3, Paula Ludovico1,2
This review describes recent findings that shed light on how longevity pathways and metabolic status impact maintenance of the proteome in both yeast ageing paradigms. These findings demonstrate that yeast remain a powerful model system for elucidating these relationships and their influence on ageing regulation.
Secondary structures involving the poly(A) tail and other 3’ sequences are major determinants of mRNA isoform stability in yeast
Zarmik Moqtaderi#, Joseph V. Geisberg# and Kevin Struhl
This article comments on work published by Geisberg et al. (Cell (2014), which points to an important role for mRNA structure at 3’ termini in governing transcript stability, likely by reducing the interaction of the mRNA with the degradation apparatus.
De novo peroxisome biogenesis revisited
Marten Veenhuis and Ida J. van der Klei
This article comments on work published by Knoops et al. (JCB, 2014), which describes an alternative peroxisome formation pathway in yeast pex3 and pex19 cells, which relies on the existence of small peroxisomal remnants that are present in these cells.
Transcriptional and genomic mayhem due to aging-induced nucleosome loss in budding yeast
Zheng Hu1, Kaifu Chen2, Wei Li2 and Jessica K. Tyler2
This article comments on work published by Zheng et al. (Genes and Development, 2014), which investigated a loss of histones during replicative aging in budding yeast, which was also accompanied by a significantly-increased frequency of genomic instability including DNA breaks, chromosomal translocations, retrotransposition, and transfer of mitochondrial DNA into the nuclear genome.
The Parkinson’s disease-associated protein α-synuclein disrupts stress signaling – a possible implication for methamphetamine use?
Shaoxiao Wang1 and Stephan N. Witt1,2
This article comments on work published by Wang et al. (PNAS, 2012), which reported that human α-syn, at high expression levels, disrupts stress-activated signal transduction pathways in both yeast and human neuroblastoma cells. Disruption of these signaling pathways ultimately leads to vulnerability to stress and to cell death.
Massive gene swamping among cheese-making Penicillium fungi
Jeanne Ropars1,2, Gabriela Aguileta1,2,3, Damien M. de Vienne4,5 and Tatiana Giraud1,2
This article comments on work published by Cheeseman et al. (Nat Comm, 2014), which indicates that horizontal gene transfer is a crucial mechanism of rapid adaptation, even among eukaryotes.
Genome-wide studies of telomere biology in budding yeast
Yaniv Harari and Martin Kupiec
In the last decade, technical advances have allowed carrying out systematic genome-wide screens for mutants affecting various aspects of telomere biology. In this review we summarize these efforts, and the insights that this Systems Biology approach has produced so far.
Understanding the molecular mechanisms of human diseases: the benefits of fission yeasts
August 2, 2024
Here we collect the latest laboratory protocols and bioinformatics tools for the fission yeasts to highlight the many possibilities available to the research community. In addition, we present several limiting factors that everyone should be aware of when working with yeast models.
Characterising glycosaminoglycans in human breastmilk and their potential role in infant health
July 4, 2024
Glycosaminoglycans are bioactive components present in breast milk and play a potential key role in determining infant health yet are overlooked by many contemporary studies. This review explores their relevance, use and characterisation techniques.
From microbes to medicine: harnessing the gut microbiota to combat prostate cancer
May 23, 2024
The gut microbiome (GM) has been identified as a crucial factor in the development and progression of various diseases, including cancer. This review highlights the important role that the GM may play in the development and progression of prostate cancer, through its influence on chronic inflammation, immune modulation, and other pathogenic mechanisms.
The cAMP-PKA signalling crosstalks with CWI and HOG-MAPK pathways in yeast cell response to osmotic and thermal stress
March 15, 2024
During industrial fermentation yeast strains are exposed to fluctuations in oxygen concentration, osmotic pressure, pH, ethanol concentration, nutrient availability and temperature. The scope of this review is to outline the advancement of knowledge about the cAMP-PKA signalling and the crosstalk of this pathway with the CWI and HOG-MAPK cascades in response to the environmental challenges heat and hyperosmotic stress.
Biofilm tolerance, resistance and infections increasing threat of public health
September 26, 2023
The review explores the role of biofilms in the development of bacterial resistance mechanisms and proposed therapeutic intervention strategies for biofilm related diseases.
Infinity war: Trichomonas vaginalis and interactions with host immune response
March 31, 2023
Trichomonas vaginalis is the pathological agent of human trichomoniasis with an incidence of 156 million cases worldwide. This review highlights parasite strategies to activate and stimulate or evade variated and complex immunological mechanisms related to the symptoms and clinical complications observed here.
Effects of the intestinal microbiota on prostate cancer treatment by androgen deprivation therapy
November 15, 2022
Prostate cancer (PC) can be kept in check by androgen deprivation therapy (ADT, usually with the androgen synthesis inhibitor abiraterone acetate or the androgen receptor antagonist such as enzalutamide) until the tumor evolves to castration-resistant prostate cancer (CRPC). The transition of hormone-sensitive PC (HSPC) to CPRC has been explained by cancer cell-intrinsic resistance mechanisms. Recent data indicate that this transition is also marked by cancer cell-extrinsic mechanisms such as the failure of ADT-induced PC immunosurveillance, which depends on the presence of immunostimulatory bacteria in the gut. Moreover, intestinal bacteria that degrade drugs used for ADT, as well as bacteria that produce androgens, can interfere with the efficacy of ADT. Thus, specific bacteria in the gut serve as a source of testosterone, which accelerates prostate cancer progression, and men with CRPC exhibit an increased abundance of such bacteria with androgenic functions. In conclusion, the response of PC to ADT is profoundly influenced by the composition of the microbiota with its immunostimulatory, immunosuppressive and directly ADT-subversive elements.